ICVX Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 30.59%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $229,350.00
Icosavax Share Price & Price History
Current Price: $15.31
Price Change: +0.30 (1.20%)
As of 02/20/2024 01:00 AM ET
Icosavax Insider Trading History
Icosavax Institutional Trading History
Data available starting January 2016
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington. As of February 19, 2024, Icosavax, Inc. operates as a subsidiary of AstraZeneca PLC.
Read More on Icosavax
Today's Range
Now: $15.31
52 Week Range
Now: $15.31
Volume
N/A
Average Volume
1,215,776 shs
Market Capitalization
$766.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.28
Who are the company insiders with the largest holdings of Icosavax?
Icosavax's top insider investors include:
- Adam K Simpson (CEO)
- Douglas Holtzman (Insider)
- Niranjan Kanesa-Thasan (Insider)
- Cassia Cearley (Insider)
- Elizabeth Bekiroglu (General Counsel)
- Thomas Joseph Russo (CFO)
Learn More about top insider investors at Icosavax.